BackgroundCheck.run
Search For

Rory A Curtis, 6232 Birdsong Pkwy, Orchard Park, NY 14127

Rory Curtis Phones & Addresses

32 Birdsong Pkwy, Orchard Park, NY 14127    508-8818428   

Newry, ME   

78 Hardwick Rd, Ashland, MA 01721    508-8818428   

9 Thayer St, Framingham, MA 01702    508-8720104    508-8818428   

31 Constitution Dr, Southborough, MA 01772    508-4908626   

Wellesley, MA   

Croton on Hudson, NY   

Millport, NY   

Social networks

Rory A Curtis

Linkedin

Work

Company: Elixir pharmaceuticals, inc. Address: 320 Putnam Ave, Cambridge, MA 02139 Phones: 617-9957000 Position: Director resident Industries: Commercial Economic, Sociological, and Educational Research

Mentions for Rory A Curtis

Rory Curtis resumes & CV records

Resumes

Rory Curtis Photo 32

Rory Curtis

Location:
United States

Publications & IP owners

Us Patents

Therapeutic Compounds And Uses Thereof

US Patent:
7897765, Mar 1, 2011
Filed:
Feb 9, 2009
Appl. No.:
12/367585
Inventors:
Peter Distefano - Southboro MA, US
Andrew Napper - Salem MA, US
Rory Curtis - Ashland MA, US
Jay Luly - Wellesley MA, US
Manuel A. Navia - Lexington MA, US
Russell J. Thomas - Siena, IT
Jean-Francois Pons - Abingdon, GB
Jeffrey O. Saunders - Acton MA, US
Assignee:
Elixir Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 401/00
US Classification:
546 17
Abstract:
Compounds of formula (I) are described hereinThe compounds can be used, for example, to modulate growth hormone secretagogue receptor (GHS-R). In some instances, the compounds can be used to treat obesity.

Sirt Inhibitors That Bind To Nad

US Patent:
8486990, Jul 16, 2013
Filed:
Apr 14, 2009
Appl. No.:
12/423751
Inventors:
Andrew Napper - Salem MA, US
Peter DiStefano - Southboro MA, US
Rory A. Curtis - Ashland MA, US
Jeffrey Hixon - Salisbury MA, US
Thomas McDonagh - Acton MA, US
L. Julie Huber - Newton MA, US
Jonathan M. Solomon - Somerville MA, US
Russell J. Thomas - Siena, IT
Jean-Francois Pons - Oxford, GB
Assignee:
Elixir Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31/403
C07D 209/56
US Classification:
514411, 548448
Abstract:
Compound of formula (I).

Novel Potassium Channel Molecules And Uses Therefor

US Patent:
2002002, Mar 7, 2002
Filed:
Dec 12, 2000
Appl. No.:
09/735169
Inventors:
Rory Curtis - Southborough MA, US
Assignee:
Millennium Pharmaceuticals, Inc.
International Classification:
C12Q001/68
G01N033/53
C07H021/04
C12P021/06
C12N015/00
C12N015/09
C12N015/63
C12N015/70
C12N015/74
C07K005/00
C07K007/00
C07K016/00
C07K017/00
A61K038/00
C12N005/00
C12N005/02
C12N001/00
US Classification:
435/069100, 536/023500, 435/320100, 435/325000, 530/324000, 435/007100, 435/810000, 435/975000, 435/006000
Abstract:
09735169 The invention provides isolated nucleic acids molecules, designated TWIK nucleic acid molecules, which encode proteins involved in potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing TWIK nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a TWIK gene has been introduced or disrupted. The invention still further provides isolated TWIK proteins, fusion proteins, antigenic peptides and anti-TWIK antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

57256 And 58289, Novel Human Transporters And Uses Thereof

US Patent:
2002002, Mar 7, 2002
Filed:
May 17, 2001
Appl. No.:
09/860232
Inventors:
Rory Curtis - Southborough MA, US
International Classification:
C12P021/02
C12N005/06
C12N009/00
C07H021/04
US Classification:
435/183000, 435/069100, 435/325000, 435/320100, 536/023200
Abstract:
The invention provides isolated nucleic acids molecules, designated MTP or 57256 or 58289 nucleic acid molecules, which encode novel MTP-related transporter molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MTP nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an MTP gene has been introduced or disrupted. The invention still further provides isolated MTP or 57256 or 58289 proteins, fusion proteins, antigenic peptides and anti-MTP antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

22105, A Novel Human Thioredoxin Family Member And Uses Thereof

US Patent:
2002003, Mar 21, 2002
Filed:
Mar 6, 2001
Appl. No.:
09/801260
Inventors:
Rory Curtis - Southborough MA, US
International Classification:
C12P021/02
C12N005/06
C07H021/04
C12N009/00
US Classification:
435/183000, 435/325000, 435/320100, 435/069100, 536/023200
Abstract:
The invention provides isolated nucleic acids molecules, designated 22105 nucleic acid molecules, which encode novel thioredoxin members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 22105 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 22105 gene has been introduced or disrupted. The invention still further provides isolated 22105 proteins, fusion proteins, antigenic peptides and anti-22105 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

54420, A Novel Human Calcium Channel

US Patent:
2002003, Mar 21, 2002
Filed:
Apr 6, 2001
Appl. No.:
09/828466
Inventors:
Rory Curtis - Southborough MA, US
Inmaculada Silos-Santiago - Cambridge MA, US
International Classification:
A61K031/00
C12Q001/68
G01N033/53
C07H021/04
C12P021/02
C12N005/06
C07K014/435
C12N009/00
US Classification:
514/001000, 435/069100, 435/325000, 536/023200, 435/006000, 435/007100, 530/350000, 530/388100, 435/183000
Abstract:
The invention provides isolated nucleic acids molecules, designated TLCC-2 nucleic acid molecules, which encode novel TRP-like calcium channel molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing TLCC-2 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a TLCC-2 gene has been introduced or disrupted. The invention still further provides isolated TLCC-2 proteins, fusion proteins, antigenic peptides and anti-TLCC-2 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

2504, 15977, And 14760, Novel Protein Kinase Family Members And Uses Therefor

US Patent:
2002004, Apr 11, 2002
Filed:
Feb 28, 2001
Appl. No.:
09/797039
Inventors:
Rachel Meyers - Newton MA, US
Rory Curtis - Southborough MA, US
International Classification:
C12P021/02
C12N005/06
C12N009/00
C07H021/04
US Classification:
435/069100, 435/325000, 435/320100, 435/183000, 536/023200
Abstract:
The invention provides isolated nucleic acids molecules, designated 2504, 15977, or 14760 nucleic acid molecules, which encode novel protein kinase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 2504, 15977, or 14760 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 2504, 15977, or 14760 gene has been introduced or disrupted. The invention still further provides isolated 2504, 15977, or 14760 proteins, fusion proteins, antigenic peptides and anti-2504, 15977, or 14760 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

Novel Potassium Channel Molecules And Uses Therefor

US Patent:
2002004, Apr 18, 2002
Filed:
Dec 12, 2000
Appl. No.:
09/735171
Inventors:
Rory Curtis - Southborough MA, US
Assignee:
Millennium Pharmaceuticals, Inc.
International Classification:
C07K014/705
C12Q001/68
C07H021/04
C12P021/02
C12N005/06
US Classification:
435/069100, 435/325000, 435/320100, 530/350000, 435/006000, 536/023500
Abstract:
The invention provides isolated nucleic acids molecules, designated TWIK nucleic acid molecules, which encode proteins involved in potassium channel mediated activities. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing TWIK nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a TWIK gene has been introduced or disrupted. The invention still further provides isolated TWIK proteins, fusion proteins, antigenic peptides and anti-TWIK antibodies. Diagnostic methods utilizing compositions of the invention are also provided.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.